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Irritable Bowel Syndrome (IBS) is a prevalent disease around 
the world. It is estimated that 10%-20% of the general population 
suffered from the disease, regards to standard scales like ROME 
II.1-3 It is about 2 times more prevalent in women compared to men 
and it is difficult differentiating from celiac disease. Celiac is a type 
of mal-absorption in small intestinal which is caused in genetically 
predisposed individuals exposed to gluten-contained regiment.1
Studies  in  European  countries  showed  that  more  than  1% 
of  general  population  has  celiac  disease.4,5  Recent  advances  in 
diagnostic methods and achievement to diagnostic tests with high 
sensitivity and specificity result in higher prevalence of the celiac 
disease than what was estimated before and can be presented with 
atypic or non-gastrointestinal symptoms. Symptoms of the disease 
can be similar to IBS, thus celiac patient may be treated as IBS. 
Recent studies have been reported increasing the prevalence of 
celiac in IBS patients compared to normal population.3
Celiac  serologic  tests  are  not  requested  routinely  in  IBS 
patients. Celiac disease is treatable and recovered with gluten-free 
diet; therefore this study was designed to determine the prevalence 
of celiac in IBS patients to decide about considering this in lab test 
requests for IBS work-up.
This case-control study was done on IBS patients (diagnosed 
by ROME II criteria) referred to gastrointestinal clinic during a 
2-years period (2006-2008) and including in the study voluntarily. 
IBS  patients  were  labeled  when  other  laboratory  tests  were 
reported normal (Na, K, Bun, Cr, CBC, ESR, T3, T4, T3RU and 
colonoscopy & sigmoidoscopy in patients older than 50 years-old) 
and have ROME II criteria.
Control  group  were  whom  without  any  gastrointestinal 
disease, chronic disease or IBS and were age and sex matched with 
case group. One hundred and sixty one cases and 172 controls were 
enrolled in the study .All had informed consent and demographic 
questionnaires were completed for all, and then referred to the 
certain laboratory. Tissue transglutaminase antibody was checked 
by ELISA method (Orthentek kit), in the research laboratory.
Mean age was 31.82 ± 10.95 years in cases and 32.97 ± 13.08 years 
in controls. Male to female ratio was about 0.8 in both groups. 
(p=0.52).  Diarrhea  predominance  was  reported  in  87.2%  and 
others were constipation predominant (p=0.32).
In  both  groups  Persian  tribe  was  the  most  frequent  type. 
One positive TTG-Ab was seen in each group (p=0.66). These 
individuals were women from Persian tribe. In the case group, 
this positive patient was in 50-59 years-old age group and diarrhea 
predominant. In the control group she was in 30-39 years old age 
group.
As  the  results  showed  the  prevalence  serologic  of  celiac, 
characterized by tTG antibody was 0.62% in IBS patients and 
0.58% in healthy controls. Other similar studies in Turkey,6 and 
United Kingdome,7 reported no positive tTG-Ab in IBS patients. 
On the other hand, some authors detected a low prevalence of 
positive celiac cases in IBS.8,9
In Iran, it was reported a little higher in IBS patients compared 
to healthy controls.8,10 In the most recent study done in Tehran 
(2008),  no  one  had  positive  serologic  test  of  IgA  anti-TTG 
antibody in IBS patients.11
According  to  the  wide  variation  in  the  prevalence  of 
celiac  disease  exists  between  different  setting  with  different 
characteristics  of  patients  and  various  serological  tests,  now  it 
is the time to decide about considering celiac serologic tests in 
suspected IBS patients, keeping in mind these controversies.
Due  to  the  AGA  guidelines  and  recent  publication  of  the 
ROME working team, serologic tests for CD in the work up of 
all IBS patients is not recommended. Clinical characteristics and 
prevalence of CD in the studied region are among the indicators 
which  is  suggested  by  ROME  III  to  be  considered  when  IBS 
patient is referred to Gastroenterology clinic.1
As  it  has  been  discussed  in  other  studies,11  physician  clinical 
judgment is the cornerstone of making decision about referring 
IBS patient for CD lab test.
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